Presentations

Company presentation
September 2018
PDF

H1 2018 results
August 2, 2018
PDF

Annual General Meeting 2018
June 28, 2018
PDF

World Vaccine Congress 2018
April 4, 2018
Developing a vaccine against Lyme disease
Zika Virus Vaccine Candidate VLA1601

FY 2017 results
March 22, 2018
PDF

J.P. Morgan Healthcare Conference
January, 2018
PDF

9M financial results 2017
November 9, 2017
PDF

H1 financial results 2017
August 31, 2017
PDF

Jefferies 2017 Global Healthcare Conference
June 08, 2017
PDF

Q1 results 2017
May 11, 2017
PDF

17th World Vaccine Congress 2017
April 11, 2017
PDF (Lyme disease)
PDF (Mosquito-transmitted disease)

FY 2016 results
March 23, 2017
PDF

J.P. Morgan Healthcare Conference
January, 2017
PDF

Q3/9M 2016 results
November 9, 2016
PDF

H1 results 2016
August 31, 2016
PDF

AGM presentation
June 2016
PDF

Q1 results 2016
May 11, 2016
PDF

Q4 & FY results 2015
March 21, 2016
PDF

J.P. Morgan Healthcare Conference
January, 2016
PDF

Clostridium difficile KOL call
November 12, 2015
PDF

Q3 results 2015
November 10, 2015
PDF

H1 results 2015
August 31, 2015
PDF

AGM presentation
June, 2015
PDF

Q1 Results 2015
May 12, 2015
PDF

European Smallcap Event Paris - (Presentation in French)
April 27, 28 2015
PDF

Q4 & Annual Results 2014
March 20, 2015
PDF

A leading pure-play vaccine company - Analyst Presentation
January 5, 2015
PDF

Q3 Results 2014
November 6, 2014
PDF

H1 Results 2014
August 8, 2014
PDF

Q1 Results 2014

May 13, 2014

PDF

FY Results 2013
March 24, 2014
PDF

Q3 Results 2013
November 5, 2013
PDF

H1 Results 2013
August 28, 2013
PDF

Annual Results 2011
April, 2012
PDF

Annual Results 2010
March 28, 2011
PDF

Annual Results 2009
April 6, 2010
PDF

Annual Results 2008
April 6, 2009
PDF

Please update your browser...